ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628185 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628185; 2) Community: the network communities that were significantly associated with the response to NSC 628185; 3) Molecule: the relationships between components within communities and NSC 628185; 4) MDR: the compounds that were significantly associated with the NSC 628185.

NSC Compound Enrichment Correlation
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0342636096654271 0.13323609
NSC 743530 Null 0.0342636096654271 0.21281539
NSC 748715 Null 0.0342636096654271 0.18671648
NSC 756053 Null 0.0342636096654271 0.37992643
NSC 758881 Orlistat (USAN) 0.0342636096654271 0.09983833
NSC 87222 ACTINOMYCIN C3 0.0342636096654271 0.15752947
NSC 24189 Null 0.0342636096654276 0.19707399
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.0342636096654276 0.16104584
NSC 349644 CYANOCYCLINE A (CHUGAI) 0.0342636096654276 0.092999722
NSC 364170 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a 0.0342636096654276 0.40015663
Total:42  Current:30    [First] [Prev] [Next] [Last]